About 72,200 results
Open links in new tab
Focus: Merck could keep its patent edge by shifting Keytruda …
Merck keeps deal focus with Keytruda patent cliff on horizon
Merck on deals hunt as patent cliff looms for top cancer drug
Merck: Keytruda Patent Expiry Nears With Replacement Yet To Be …
Ten-Year Data for Merck’s KEYTRUDA® (pembrolizumab) …
Keytruda remains Merck & Co’s biggest 2023 success story as patent …
Merck Announces Settlement and License Agreement Resolving KEYTRUDA …
Merck Scores Major Drug Approval, Easing Pain From Keytruda Patent ...
Keytruda beaten by Summit’s bispecific in NSCLC - Yahoo Finance